Abdomen distended
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abdominal Pain
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal atrioventricular conduction
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormal cell morphology
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of retinal pigmentation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the extraocular muscles
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of the mitochondrion
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of the spinocerebellar tracts
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Acidosis, Lactic
|
0.400 |
Biomarker
|
phenotype |
HPO |
|
|
|
Acidosis, Lactic
|
0.400 |
Biomarker
|
phenotype |
CTD_human |
A novel homozygous RRM2B missense mutation in association with severe mtDNA depletion.
|
19138848 |
2009 |
Adenocarcinoma
|
0.010 |
GeneticVariation
|
group |
BEFREE |
To explore the p53R2's candidacy for a suppressor in gastric tumorigenesis, we examined the expression and mutation status of p53R2 in 166 gastric specimens including 90 primary adenocarcinomas and 15 cell lines.
|
11920641 |
2002 |
Adenocarcinoma of colon
|
0.010 |
Biomarker
|
disease |
BEFREE |
Univariate and multivariate analysis revealed that p53R2 is negatively related to the metastasis of colon adenocarcinoma samples (odds ratio, 0.23; P < 0.05); hRRM2 increases the risk of metastasis in colon cancer, but did not show significantly.
|
17311703 |
2007 |
Adenoma of large intestine
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We screened the p53R2 gene coding regions and a regulatory region which contains a p53 binding sequence in 100 patients with colorectal adenoma and 100 control subjects using PCR, cold SSCP, and direct DNA sequencing.
|
16127747 |
2005 |
Adult Myelodysplastic Syndrome
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
To determine the clinical relevance of p53R2 induction, we measured p53R2 expression in bone marrow samples from 15 myelodysplastic syndrome/acute myelogenous leukemia (MDS/AML) patients undergoing decitabine therapy. p53R2 mRNA and protein were induced in 7 of 13 (54%) and 6 of 9 (67%) patients analyzed, respectively, despite a lack of methylation changes in the p53R2 promoter.
|
19010910 |
2008 |
Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy
|
0.300 |
GermlineCausalMutation
|
phenotype |
ORPHANET |
Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics.
|
23107649 |
2012 |
Advanced breast cancer
|
0.010 |
Biomarker
|
disease |
BEFREE |
Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine.
|
24215511 |
2013 |
Aminoaciduria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Anemia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Anterior hypopituitarism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Anxiety
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Areflexia of lower limbs
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Atrial Fibrillation
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Atrophic muscularis propria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Bilateral ptosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|